FLGT Financials
Fulgent Genetics Inc - Financial statements & key metrics
Stock Price
$19.59
Market Cap
$586.65M
EPS
$-1.40
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$283.47M
Gross Profit
-
Operating Income
-
Net Income
$-43.82M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$1.22B
Total Liabilities
$90.81M
Shareholders Equity
-
Cash & Equivalents
$55.14M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$21.06M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-18.3%
Net Margin
-13.6%
ROE
-3.9%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is FLGT revenue?
FLGT's most recent quarterly revenue was $283.47M. Annual revenue can be calculated by summing the four most recent quarters.
Is FLGT profitable?
FLGT reported a loss of $43.82M in the most recent quarter. The net profit margin is -13.6%.
What is FLGT market cap?
FLGT has a market capitalization of $586.65M, making it a small-cap stock.
Does FLGT have debt?
View FLGT's balance sheet for debt information.
What is FLGT cash flow?
Cash flow data is available in the full financial statements.